COST vs CVSA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
COST shows neutral fundamentals based on deterministic rules. Financial strength is stable (F-Score 4/9). Mixed signals with both opportunities and risks present.
CVSA presents a dichotomy between strong operational performance and deteriorating technicals. While the Piotroski F-Score of 4/9 indicates stable but non-optimal financial health, the company boasts an exceptional earnings track record with consistent beats over 25 quarters. Valuation is attractive on a PEG basis (0.82), though the current price of $107.63 trades at a premium to both the Graham Number ($77.96) and Intrinsic Value ($95.4). The primary concerns are a bearish technical trend (-29.6% over 6 months) and weak liquidity ratios.
Compare Another Pair
Related Comparisons
COST vs CVSA: Head-to-Head Comparison
This page compares Costco Wholesale Corporation (COST) and Covista Inc. (CVSA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.